Reduced Dose Post Transplant Cyclophosphamide (PTCy) Is Associated with Improved Count Recovery without Significant Acute and Chronic GVHD

Key Points

• Improved count recovery is observed with reduced dose of cyclophosphamide after transplant, indicating a potential benefit.
• Count recovery rates in this cohort were notably higher, with no significant increase in acute or chronic GVHD.
• Observational analysis recorded outcomes of transplant recipients receiving varied cyclophosphamide doses to assess recovery.
• This study highlights the need for optimized dosing strategies to mitigate GVHD while promoting effective recovery.